MD FRCPC, MPH
Clinical Assistant Professor of Medicine
BC Cancer – Vancouver
Dr. Ali Weppler is a Clinical Assistant Professor at the University of British Columbia and a medical oncologist specializing in melanoma/skin cancers at BC Cancer – Vancouver. She received a BSc in Life Sciences from Queen’s University and an MD from Western University, followed by residencies in Internal Medicine and Medical Oncology. Dr. Weppler subsequently completed a fellowship in Melanoma and Immuno-oncology at the Peter MacCallum Cancer Centre in Melbourne, Australia and a Masters of Public Health from the Harvard School of Public Health. Her research focuses on overcoming mechanisms of resistance to checkpoint inhibitors and exploring the role that elements of the tumor microenvironment play in response to immunotherapy. She also has a research focus in rare skin cancers, such as Merkel cell carcinoma.
MD, MS
Clinical Associate Professor of Medicine
BC Cancer – Vancouver
Medical Oncologist, BC Cancer Agency
Dr. Zahi Mitri is a medical oncologist at the BC Cancer Agency – Vancouver Center with a focus on breast cancer. He completed his hematology/medical oncology fellowship training at the MD Anderson Cancer Center, as well as a Masters in Clinical and Translational Sciences from UT Graduate School of Biomedical Sciences. Prior to joining UBC and BC Cancer, Dr. Mitri served as an Associate Professor of Medicine and the Program Director for Breast Cancer at the Oregon Health and Science University Knight Cancer Institute in Portland, Oregon. Dr. Mitri’s research interest focus on novel therapeutics as well as predictive biomarkers in breast cancer, with a particular interest in triple negative breast cancer.
MD FRCPC, PhD
Assistant Professor (Associate Member)
BC Cancer – Vancouver
Assistant Professor, Department of Urologic Sciences
Associate Member, Department of Medicine
Dr. Lucia Nappi is a medical oncologist – clinician scientist, MD and PhD.
She is an assistant professor in the department of Urologic Sciences at the University of British Columbia and a senior research scientist at the Vancouver Prostate and works as medical oncologist in the GU group at the BC Cancer in Vancouver.
Her main research focus involves the discovery and validation of biomarkers in GU cancers, mainly in prostate and testis cancer patients.
She has got several grants and awards including the Prostate Cancer Foundation Young Investigator award and the Michael Smith Foundation Health Professional Investigator award (2020), the operational CIHR grant in 2021, the R01/R37 NIH grant and the career development award from the US department of defense (2022).
She is the vice-chair of the SWOG Adolescent and Young Adults (AYA) committee and the chair of the international SWOG- S1823 / CCTG GCC.1 clinical trial.
MD FRCPC, MBBS, PhD
Associate Professor of Medicine
BC Cancer – Vancouver
Medical Oncologist, BC Cancer
Dr Yvette Drew is a Medical Oncologist and Associate Professor at BC Cancer Centre Vancouver and the University of British Columbia. She specialises in the care and management of patients with gynecological cancers and the development and delivery of early phase clinical trials. Dr Drew joined the team in Vancouver in 2021. Prior to this she worked as a Senior Lecturer/Medical Oncologist in the UK and was translational gyne cancer lead and deputy lead of the Experimental Medicines Centre in Newcastle. She undertook specialist medical oncology training at the Beatson West of Scotland cancer centre, Glasgow and the Northern Centre for Cancer Care, Newcastle. During this time, she was awarded a Cancer Research UK funded PhD fellowship investigating the role of PARP inhibitors in homologous recombination deficient ovarian cancer. During her PhD she won a merit award for her research from the American Society of Clinical Oncology and was awarded the Medical Sciences doctoral prize. Since coming to Vancouver, she has been awarded clinical trial research funding from Ovarian Cancer Canada and a 5-year Michael Smith Health Research BC Professional Investigator award. She is an active member of the GYN and phase 1 clinical trials groups within Vancouver and the Canadian Clinical Trials Group (CCTG). Dr Drew is the incoming chair of the CCTG IND committee. She has been principal investigator of multiple early phase to phase 3 studies. Research interests are the targeting of DNA repair pathways as treatment for cancer and novel therapies in gynaecological malignancies.
MD FRCPC
Clinical Associate Professor of Medicine
BC Cancer – Vancouver
Post-Graduate Fellowship Director, Division of Medical Oncology
My clinical practice includes on the management of thoracic and head&neck malignancies. My research involves evaluating the impact of therapies proven in clinical trials in the real world through population-based analysis. My current focus is on developing a learning health care system with a real-world data evidence-generation framework to inform healthcare decision-makers.
MD FRCPC
Clinical Associate Professor of Medicine
BC Cancer – Vancouver
Dr. Alannah Smrke (she/her) treats sarcoma and gynecological cancers. She completed her training at McMaster University and the University of British Columbia. She completed a fellowship in Sarcoma at The Royal Marsden Hospital in London, UK. She is interested in precision oncology, treatment of rare tumours and adolescent and young adult oncology.
MD FRCPC
Clinical Professor of Medicine
BC Cancer – Vancouver
Medical Oncologist, BC Cancer
Head, Department of Medical Oncology, BC Cancer
Chair, British Columbia Genitourinary Tumour Group
Dr. Kollmannsberger is a staff medical oncologist and Head, Department of Medical Oncology at BC Cancer, Vancouver Cancer Centre, as well as a Clinical Professor in the Division of Medical Oncology at the University of British Columbia. He has a full-time clinical practice focusing on genitourinary cancers and new drug development. He currently is the Chair of the BC Genitourinary Tumor Group as well as the GU Clinical Trials Unit at BC Cancer – Vancouver Center.
Dr. Kollmannsberger’s research is focused on genitourinary malignancies with a special interest in testicular and renal cell cancer. Nationally and internationally, he has contributed to numerous trials in the field of renal cell carcinoma and testicular cancer. He has authored or co-authored more than 280 publications in peer-reviewed journals including the Journal of Clinical Oncology, Annals of Oncology, Cancer Discovery, European Urology, and the New England Journal of Medicine.
He has repeatedly served as faculty for the Annual meeting of the American Society of Clinical Oncology (ASCO), the Annual Meeting of the European Society of Medical Oncology (ESMO), and as faculty and program chair for the ASCO Genitourinary Cancers Symposium.
Etiam fringilla turpis at eros fermentum, a tincidunt sapien commodo. Integer egestas imperdiet eros vitae rutrum. Quisque iaculis ullamcorper fermentum. Maecenas tortor tortor, euismod vitae felis eget, condimentum scelerisque ante. Nullam vitae ipsum enim. Integer at suscipit nunc, ut ornare purus. Curabitur ut enim id massa aliquam tristique. Donec non lacinia dui, eu volutpat erat. Sed quis urna est. Vivamus vestibulum felis id neque porta vestibulum. In congue dui est, vitae semper odio feugiat lacinia. Sed vitae bibendum metus, id convallis metus.
- Etiam ut quam vitae dolor tristique maximus ut ut nisl.
- Nam ac leo id lorem sollicitudin suscipit ac vel ante.
- Phasellus nec lorem non erat posuere consequat.
- Duis in dui ac nibh eleifend efficitur.
- Donec sit amet nulla bibendum tortor ornare suscipit.
- Donec efficitur risus at diam sagittis ornare.
- Suspendisse accumsan turpis vitae enim tincidunt, sed sagittis urna molestie.
- Nunc venenatis metus vitae sodales tempor.
- Nunc bibendum diam eu quam commodo euismod.
- Integer tristique lorem feugiat urna fermentum iaculis.
- In imperdiet nulla eu sagittis bibendum.
Nam at arcu nibh. Pellentesque diam tortor, venenatis eget congue et, vestibulum id ante. Suspendisse maximus justo eget nulla tristique eleifend. Suspendisse eu tempor nulla. Nam purus massa, maximus ac varius a, iaculis ut sapien. Nunc tincidunt nisi nec vestibulum gravida. Fusce hendrerit felis eu volutpat bibendum. Donec consequat, mi et eleifend pulvinar, nibh purus cursus ex, eget aliquet libero tortor id nulla. Sed dignissim arcu consectetur dui congue, ut hendrerit enim vulputate. Vestibulum placerat nibh purus, vel consequat nibh blandit vel. Nullam consectetur, dolor id pulvinar ultrices, odio dolor accumsan neque, in sollicitudin erat orci a arcu. Nam vestibulum, nulla in suscipit sagittis, justo dui finibus est, ac egestas purus turpis in ipsum. Curabitur rutrum egestas eros, ac viverra eros egestas in.
San Francisco, CA – 2023 Genitourinary Symposium – Chair Dr. Christian Kollmannsberger gives the Welcome of the Day during Opening session at the 2023 Genitourinary Cancers Symposium, Thursday February 16, 2023. Photo by © ASCO/Todd Buchanan 2023
